A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological ...
Tags: diflunisal, anti-inflammatory drug, transthyretin amyloidosis, arthritis